Delivery Order SPE2DB22D2214-SPE2DB24FS2YC
- Not listed
- This federal contract award, valued at $3,231.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Lyrica 100 mg capsules, a medication used to treat various conditions including neuropathic pain, fibromyalgia, and seizures. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This federal contract award, valued at $1,044.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a medication used to treat various conditions including neuropathic pain, seizures, and fibromyalgia. The contract has a firm fixed price and is a delivery order with a completion date of December 22, 2023. AmerisourceBergen holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,911.60 firm fixed-price delivery order contract is for the provision of Lyrica 50 mg capsules. The contract has an ultimate completion date of February 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,778.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 100 mg capsules. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,905.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Lyrica 300 mg capsules, a medication used for the treatment of neuropathic pain, nerve pain, and fibromyalgia. The contract has an ultimate completion date of December 30, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract...
- This federal contract award, valued at $11,508.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lyrica 50 mg capsules to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a medication used to treat certain types of nerve pain. The contract has a ceiling value of $1,182.32 and a completion date of March 17, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation,...
- This federal contract award, valued at $3,650.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order (SPE2DB20D1100|SPE2DB25FB9S6) for the supply of Lyrica 50 mg capsules, a medication used to treat nerve pain. The contract has a firm fixed-price pricing type and an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,732.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 75 mg capsules, a prescription medication used to treat nerve pain. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 12, 2025. It is not designated as a set-aside contract, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,546.96 firm fixed-price delivery order is for the supply of Lyrica 50 mg capsules, a medication used to treat certain types of nerve pain. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. The award is associated with a larger Indefinite Delivery Contract...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS2YCDelivery Order
This federal contract award, valued at $8,867.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a prescription medication used to treat certain types of nerve pain. The contract has an ultimate completion date of December 14, 2023 and is structured as a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 12/13/23 |